Companies: Central Nervous System/Neurodegenerative Disorders/Multiple Sclerosis

Latest: Watch here for details of new products and services.

About Us: Pharmalicensing - Partnering solutions for the life sciences
Our Products: Overview; Partnering Search; Company Profiling; Deal Negotiation; PL Intelligence; Reports; Comparison
PL Intelligence: Overview; Industry news; Deals review; Press releases; Articles
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire; Jobs
Contact Pharmalicensing: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd

Companies
Browse

Companies

Displaying 1..10 of 20 - per page Next page
Order by

Mundipharma International

Mundipharma International seeks products in analgesia, anesthesia and oncology to market through a pan-European sales force. More

Decision Resources Inc.

The worldwide leader in market research publications, advisory services and consulting More

Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals is a specialty pharmaceutical company specific expertise in developing differentiated products in collaboration with partners and for its own CNS product portfolio. More

Valeant Pharmaceuticals UK

Valeant Pharmaceuticals is a US based specialty company with capabilities from R&D through Manufacturing and Sales and Marketing in all major world markets. More

GW Pharmaceuticals

GW Pharmaceuticals develops a range of medicines based on cannabinoids and other controlled drugs More

Amarin

Amarin Corporation plc is a neuroscience company focused on the development and commercialization of novel drugs for the treatment of CNS disorders More

Elan Corporation Plc

Elan Corporation, plc, headquartered in Dublin, Ireland, is a leading world-wide drug delivery and speciality biopharmaceutical company. More

Desitin Arzneimittel GmbH

Success in CNS More

CeNeS Pharmaceuticals

CeNeS is a drug discovery and development company focused on clinically validated targets in pain, anaesthesia and CNS. More

H. Lundbeck

Fully integrated global CNS pharmaceutical company More

Displaying 1..10 of 20 - per page Next page
Order by

Your selection

Therapeutic target: Central Nervous System del; Neurodegenerative disorders del; Multiple sclerosis del

Browse By

Industry sector: Academic/Research; Animal health; Biotechnology; Diagnostic; Drug delivery; Drug discovery; Medical device; Non-profit org./Government; Pharmaceutical; Research tools; Service
Geographic location: Africa; Asia; Australia/New Zealand; Central America; Europe; Near & Far East; North America; South America

Clients in focus...

Get the Flash Player to see this rotator.

Press releases: Pharmalicensing current industry press releases.

Products:	Partnering Search	Company Profiling	Deal Negotiation	PL Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Services
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us